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& Abstract
Introduction: Low-back or leg pain in patients suffering from
failed back surgery syndrome (FBSS) is often severe, having a
major impact on functionality and quality of life. Despite
conservative and surgical treatments, pain can be persistent.
An alternative treatment option is epiduroscopy, a minimally
invasiveprocedurebasedonmechanicaladhesiolysisofepidural
fibrosis. As epidural fibrosis is speculated to be amajor contrib-
utor in the pathophysiologic process of FBSS, this review
evaluates the effectiveness of epiduroscopy in FBSS patients.
Methods and materials: A systematic literature search was
performed in PubMed, Embase, and Cochrane databases.
Critical appraisal was performed using validated tools. Meta-
analysis was performed using generic inverse variance analysis.
Results: From the 286 identified articles, nine studies were
included. The visual analogue scale (VAS) average was 7.6 at
baseline, 4.5 at 6, and 4.3 at 12 months. The Oswestry
Disability Index (ODI) average was 61.7% at baseline, 42.8%
at 6, and 46.9% at 12 months. An average of 49% of patients
experienced significant pain relief at 6 and 37% at
12 months. Meta-analysis showed a pooled VAS mean
difference of 3.4 (2.6 to 4.1; 95% confidence interval [CI])
and 2.8 (1.6 to 4.0; 95% CI) and pooled ODI mean difference
of 19.4% (12.5 to 26.4%; 95% CI) and 19.8% (13.8 to 25.9%;
95% CI) at 6 and 12 months, respectively.
Conclusion: Current literature demonstrates a clinically rel-
evant reduction in pain and disability scores at 6 to
12 months after mechanical adhesiolysis in FBSS patients.
The quality of evidence is moderate, and the level of
recommendation is weak. Practitioners should consider the
benefits of epiduroscopy after weighing the risks for indi-
vidual patients with FBSS. &
Key Words: epiduroscopy, failed back surgery syndrome,
endoscopic adhesiolysis, systematic review, recurrent low-
back pain, leg pain
INTRODUCTION
Lower-back pain remains the major cause of disability in
most western countries, with 70% of adults experienc-
ing at least one episode of low-back pain or discomfort
during their lifetime.1 Spinal surgery is an increasingly
utilized treatment option for both degenerative and
nondegenerative diseases of the spine. Recent long-term
cohort studies demonstrated a significant increase in
spinal surgeries in the past 15 years with a fivefold
increase among the elderly.2–4 Unfortunately, 10% to
40% of patients experience recurrent or persistent low-
back pain with or without leg pain after technically
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successful spinal surgery.5,6 These symptoms are known
as failed back surgery syndrome (FBSS).7
The etiology of FBSS is not clear. Recurrent pathol-
ogy, surgical complications, inflammation, and the
formation of epidural fibrosis are considered possible
causes,8 of which epidural fibrosis most frequently
seems to be associated with FBSS.8,9 The latter consists
of dense fibrous scar tissue that can form within the
epidural space after surgery. It may lead to adhesions
to the dura mater and tether nerve roots.8 It is
hypothesized that nerve compression and accumulation
of inflammatory mediators affect nerve nutrition,
which may cause increased sensitivity and the devel-
opment of chronic neuropathic(-like) pain and noci-
ceptive pain.10
Treatment options for FBSS include physical therapy,
pain medication, interventional procedures (eg, lumbar
steroid injections and percutaneous/endoscopic adhesi-
olysis) neurostimulation, and reoperations. FBSS is often
refractory to drug therapy.11,12 Revisional surgery, to
remove epidural fibrosis, is only effective in 5% to 30%
of the cases.13,14 Interventional procedures, such as
percutaneous adhesiolysis, and physical therapy are
supported by moderate to strong evidence.11 While the
strongest long-term evidence exists for the effectiveness
of spinal cord stimulation (SCS), SCS is often reserved as
last-resort treatment modality.15,16
A relatively unknown interventional treatment for
FBSS is epiduroscopy, a minimally invasive endoscopic
procedure. The therapeutic effectiveness is allegedly
based on endoscopic adhesiolysis of epidural adhe-
sions,17,18 by mechanical movement of the catheter and
saline injection(s) surrounding the affected nerve root.10
Other forms of endoscopic adhesiolysis include laser,19
radiofrequency,20 and, chemically, administration of
ozone.21–24 After adhesiolysis, targeted drugs, such as
corticosteroids, can be accurately delivered in the
affected areas. Epidural adhesiolysis can especially
benefit patients with FBSS given the hypothesized
pathology of pain.
The reported effectiveness of epiduroscopy in studies
is promising; however, previously published systematic
reviews show moderate level of evidence (level II to III25
and level 2B+26) with a weak recommendation.7,10,27
The reviews included articles covering a heterogeneous
group of patients with different spinal pathologies,
elderly with lumbar stenosis and disc herniations with-
out previous spinal surgery, and describing a wide range
of endoscopic adhesiolysis techniques.27 The most
recent review was published in 2016.27 However, since
then several new studies, including one randomized
controlled trial (RCT), have been published.
At present, the benefits of mechanical adhesiolysis
with or without target drug placement in patients with
FBSS remain unclear. Therefore, we attempt to gather
all available evidence on the effect of epiduroscopy on
pain and functionality at 6 and 12 months after




A systematic search was conducted in three databases
(PubMed, Embase, Cochrane Database for Systematic
reviews, and Central Register of Controlled Trials) on
November 20, 2019. Search terms included “failed back
surgery syndrome” and “epiduroscopy” and their syn-
onyms (Appendix S1).
Study Selection
All studies were imported into Rayyan QCRI, a
systematic review application,28 and duplicates were
removed. Title and abstract screening was performed by
two authors (M.G., A.K.) independently using the
following inclusion criteria: original studies (both obser-
vational and interventional) written in English, Dutch,
or German language including adult patients with low-
back and/or leg pain following prior spinal surgery, who
received epiduroscopy, reporting a clinical outcome
with a minimum follow-up of 6 months. Any disagree-
ments were settled by a third author (M.R.). In the next
phase, the same authors performed full-text screening.
Further selection criteria were a study population of at
least 80% FBSS patients in the primary statistical
analyses or in secondary analyses, the use of the sacral
approach during epiduroscopy, and including only
mechanical adhesiolysis with or without targeted drug
treatment. Conference abstracts and articles with no full
text available were excluded. Backward selection was
performed on the included articles.
Quality Assessment
The PRISMA-protocol was used for this systematic
review.29 All included studies were assessed by two
authors (A.K., M.G.). The applicability of all included
studies to the research question was scored on a three-
2  GEUDEKE ET AL.
point scale (poor, moderate, good applicability) for the
domain, determinant, and outcome of the study. The
quality of all studies was assessed using the Cochrane
Risk of Bias (RoB)30 tool for RCTs, the Newcastle
Ottawa Scale (NOS)31 for nonrandomized (observa-
tional cohort and case–control) studies, and the Quality
Assessment Tool for Before–After Studies with No
Control Group of the National Institute of Health
(NIH).32 Critical appraisal tools quantified the quality
of studies on a three-point scale: poor, moderate, and
good quality. To be able to compare results, poor-
quality studies were excluded from the meta-analysis.
The quality of evidence (rated as very low, low,
moderate, or high) and associated recommendation
(weak or strong) were assessed using the Cochrane
GRADE tool.33
Data Extraction
For each study, single-arm data including the interven-
tion mechanical adhesiolysis with or without targeted
drug treatment were extracted. Outcome measures
extracted were pre- and postprocedure visual analogue
scale (VAS) or Numerical Rating Scale (NRS) for pain,
Oswestry Disability Index (ODI),34 percentage of
patients with significant pain relief (> 50% pain relief)
at 12-month follow-up, and adverse events.
The VAS on a scale from 0 to 10, where 0 represents
no pain and 10 the worst imaginable pain, was extracted
as a group average with standard deviation (SD). For
this review, VAS and NRS scores were considered
equivalent. ODI data were either presented as a score (0
to 50; 0 is minimal disability, 50 is maximal disability)
or percentage (0% to 100%; 0% to 20% is minimal
disability, 80% to 100% represents bed-bound). For the
purpose of comparison, the ODI scores were converted
into percentages. The percentage of patients with
significant relief was collected as absolute numbers and
percentages. For all studies, the definition of significant
pain relief was extracted and compared.
Meta-analysis
All outcome measures registered before epiduroscopy
are presented as baseline data. For the VAS and ODI
scores, the mean difference was calculated with standard
error (SE) at both 6 and 12 months post surgery. The
single-arm data were displayed in a forest plot. The
analysis was performed with RevMan 5.335 (The
Cochrane Collaboration’s software for preparing and
maintaining Cochrane reviews) using the generic inverse
variance (GIV) data type and a random effects analysis
model with 95% confidence interval (CI). Using a P
value equal to 0.05 as statistically significant.
RESULTS
Study Selection
The systematic search yielded 286 unique articles which
were screened on title and abstract, of which 227 did not
meet the in- and exclusion criteria. The remaining 59
articles were eligible for full-text screening. Nine articles
were included in the final analysis, and seven articles
with the highest quality were included in the meta-
analysis (Figure 1).
Study Characteristics
Two articles were RCTs,36,37 three were prospective-,38–
40 and four were retrospective41–44 observational stud-
ies. Together, they included 392 patients. Results from
one of the RCTs are reported per study arm because
both study arms included mechanical adhesiolysis with
different targeted drug treatment regimens.37 For fur-
ther study characteristics, see Table 1.
Quality Assessment
Risk of bias is shown in Appendix S2. One RCT was
rated as good37 quality and one as fair36 (Table 2a). Fair
quality was due to possible attrition bias. Follow-up
data at 3 months were used as 6-month data, and at
6 months as 12-month data if no further data were
available. Using the NOS for observational studies, four
were rated as good,39,41,43,44 one as moderate,42 and
two as poor38,40 (Table 2b). Poor quality was rated
because patients were excluded from follow-up based on
outcome or due to incomplete reporting of data. The
quality assessment using the NIH showed risk of bias in
the enrolment of participants, unaccounted or high loss
to follow-up, and small sample sizes with insufficient
power. The overall applicability was good: three studies
had good applicability37,41,42 (Appendix S2, Table 2c),
four had moderate applicability due to varying outcome
and follow-up data,37,39,40,44,45 and one study36 had
moderate applicability due to mixed population
(Appendix S3). Results from Geurts et al.38 were not
included due to exclusion of patients from follow-up
based on outcome.
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The overall quality of evidence is categorized as
“moderate” and the corresponding level of recommen-
dation “weak.” Since only single-arm data were
extracted from the RCTs, the evidence presented in the
review is based on primarily observational data. There-
fore, the evidence has the level of evidence of observa-
tional studies and cannot be considered “high.”
Results from Individual Studies
Full table of results is included in Appendix S4,
Table 3a–c.
Visual Analogue Scale. Five studies, including six study
arms, reported VAS as primary outcome at
6 months36,37,41,42 and four studies (five study arms)
at 12 months.36,37,41,42 The average was 7.6 at baseline,
4.7 at 6 months, and 4.9 at 12 months (Figure 2A,B).
This decline in VAS was significant in five out of six
study arms.
The meta-analysis for VAS at 6 and 12 months
included five study arms.36,37,41,42 Two studies were
excluded from analysis; one due to high loss of follow-
up38 and one because SE could not be calculated.44 The
pooled VAS mean difference was 3.42 (2.67 to 4.16;
Figure 1. Flowchart of systematic search, performed on November 20, 2019.
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95% CI) and 2.81 (1.60 to 4.02; 95% CI) at 6
(Figure 3A) and 12 months (Figure 3B), respectively.
Oswestry Disability Index. The ODI was the primary
outcome in one study with only 6 months follow-up.39
The ODI was reported in six study arms and five study
arms at 636,37,39,41,42 and 12 months,36,37,41,42 respec-
tively. The ODI average was 61.7% at baseline,
42.8% at 6 months, and 46.9% at 12 months (Fig-
ure 4A,B). At 6 months, the difference met the criteria
of significance in five study arms, and at 12 months in
three out of five study arms when compared with
baseline.
The meta-analysis for ODI at 6 months included six
study arms.36,37,39,41,42 One study39 failed to report an
outcome at 12 months; hence, the analysis only included
five study arms at 12 months. The pooled ODI mean
difference was 19.42% (12.47% to 26.37%; 95% CI)
and 19.84% (13.82% to 25.86%; 95% CI) at 6
(Figure 5A) and 12 (Figure 5B) months, respectively.
Pain Relief. Pain relief was defined as follows: patients
with 50% pain reduction at follow-up in five stud-
ies,36,38,40,41,43 50% improvement in global perceived
effect in one study,44 and patient status score “good”
and “very good” in one study.42 Five study arms out of
ten reported pain relief at 6 months with an average of
49.2%, ranging from 30% to 78%.36,38,42–44 At
12 months, five study arms reported pain relief with
an average of 36.6%, ranging from 22% to
48%36,38,40,41,43 (Figure 6). Due to differences in defi-
nitions and high variability in follow-up data, no meta-
analysis was performed on this outcome.
Adverse Events. No serious adverse events were
reported in the studies. Most frequent adverse events
Table 1. Study Characteristics







































Retrospective 1. FBSS patients
2. Non-FBSS
patients






















Mechanical + xylocaine, celestone,
soluspan
































Retrospective 1. Epiduroscopy Mechanical + methylprednisolone 35 49 GPE
NRS
0.25, 6
ADL, activities of daily living; FBSS, failed back surgery syndrome; GPE, global perceived effect; GSER, global subjective efficacy rating; JOA, Japanese Orthopedic Association score;
NRS, numeric rating scale; ODI, Oswestry Disability Index; PSCS, patient specific function scale; PSS, patients satisfactory scale; RDQ, Roland–Morris disability questionnaire; VAS,
visual analogue scale.
*Study arms using nonepiduroscopic techniques or consisting of non-FBSS patients were not included in this review.
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Table 3. Results of (A) Visual Analogue Scale (VAS) and (B) Oswestry Disability Index 2.0 (ODI) for each Study per
Included Study Arm prior to surgery and at 6- and 12-Month Follow-up After Epiduroscopy. (C) Percentage of Patients










VAS at 6 Months (SD; P
value)





1. M¶ 18 (100%) — — —
Ceylan et al. 2019 1. + 2.‡ M + C† 82 (100%) 7.67 (0.69) 3.28(0.50) (P < 0.001)* 3.02(0.57) (P < 0.001)*
Geurts et al. 2002. 1. M + C† 12 (100%) 7.3(0.94) 3.2(2.98) 1.2(0.85)
Hazer et al. 2018 1. M¶ 66 (100%) 7.3 (1.1) 3.2 (1.5) (P < 0.001)* 3.7 (1.6) (P < 0.001)*
Manchikanti et al.
2005
1. M + C† 50 (84%) 9.0(0.9) 5.3(2.5) (P < 0.001)* 5.7(2.5) (P < 0.001)*
Manchikanti et all.
1999
1. M + C† 60 (100%) — — —








5.09 (P = 0.024)*
5.65 (P = 0.037)*
6.45 (P = 0.714)































ODI at 6 Months (%)
(SD; P value)





1. M¶ 18 (100%) — — —
Ceylan et al. 2019 1. + 2.‡ M + C† 82 (100%) 64.94(5.42) 42.68(4.36) (P < 0.001)* 41.74(4.3) (P < 0.001)*
Geurts et al. 2002. 1. M + C† 12 (100%) — — —
Hazer et al. 2018 1. M¶ 66 (100%) 73 (16) 38 (17) (P < 0.002)* 44 (17) (P < 0.002)*
Manchikanti
et al. 2005
1. M + C† 50 (84%) 72(9) 50(23.4) (P < 0.001)* 50(25.4) (P < 0.001)*
Manchikanti
et all. 1999











49.18 (P = 0.055)
40.26 (P = 0.024)*
53.68 (P = 0.40)















42 (11) (P = 0.6241)
33.8(10.2) (P = 0.0209)*










Number of Patients per
Study Arm (% FBSS)
Definition of
Pain Relief
% of Patients with Pain
Relief at 6 Months
% of Patients with Pain



















1 M¶ 66 (100%) > 50%
reduction VAS
— 62% (P = 0.011)
Manchikanti
et al. 2005
1 M + C† 50 (84%) > 50%
reduction VAS
%
56%* (P < 0.001) 48%* (P < 0.001)
Manchikanti
et all. 1999






































Tuijp et al. 2018 1 M + C† 35 (100%) > 50%
reduction GPE
30% —
FBSS, failed back surgery syndrome; GPE, global perceived effect; PSS, patients satisfactory scale; SD, standard deviation.
*Significant difference (P < 0.05) when compared with baseline.
†
M + C, mechanical adhesiolysis and targeted drug placement used during epiduroscopy.
‡
Combined data were reported in the original article.
§
Study arm numbers correspond
with Table 2.
¶
M, only mechanical adhesiolysis used during epiduroscopy.
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were dural and arachnoid puncture or rupture; with a
combined 22 cases, leading to six cases of postdural
puncture headache.
DISCUSSION
Current literature demonstrates an overall clinically
relevant reduction in pain and disability scores 6 and
12 months after mechanical adhesiolysis using epiduro-
scopy, with a mean reduction in pain score by 2.8 points
and a mean reduction in disability by approximately
20% 1 year after the procedure. This suggests that
epiduroscopy can be an effective treatment for patients
with FBSS.
The overall quality of evidence is categorized as
“moderate” and the corresponding level of recommen-
dation as “weak.” Before we further discuss the clinical
data, we first want to explain why the quality of
evidence is categorized as moderate because there are
two RCTs included in the review both showing a
beneficial effect of epiduroscopy. In the RCT by Rapcan
et al.,37 both study arms included mechanical adhesiol-
ysis. Data from both arms were extracted for the meta-
analysis and are treated as observational data. In the
RCT by Manchicanti,36 the intervention mechanical
adhesiolysis was compared with corticosteroid injection
only. However, the study was rated as fair quality due to
possible attrition bias. Using the Cochrane GRADE
tool, the maximum quality was “high” with the inclu-
sion of two RCTs. However, it was downgraded by one
point to moderate based on the arguments described
above. This can be interpreted as that the true effect is
likely to be close to the estimate of the effect, but there is
a possibility that it is substantially different.
Focusing on the data presented by the different
studies, the treatment effect does not benefit patients
equally. At 6 months after epiduroscopy, 30% to 78%
of patients report relief of pain, a highly variable
proportion. One year after epiduroscopy, this decreases
to 22% to 48% of patients. Hence, the overall reduction
in VAS is caused by a select group of patients that
benefits considerably from epiduroscopy. In order to
identify patients with higher chance of success, it is of
critical importance to investigate prognostic factors
associated with the outcome of epiduroscopy in patients
with epidural fibrosis.45
Several studies have demonstrated that the type of
spinal surgery correlates with the epiduroscopic out-
come. Ceylan et al.42 showed that patients with stabi-
lizing spine surgery have a poor outcome compared with
nonstabilizing spinal surgery (like disc herniations and
laminectomies). This finding is supported by a previous
study, which demonstrated that patients after anterior
or posterior lumbar interbody fusion have a worse
clinical outcome after epiduroscopy when compared
with discectomy and laminectomy.46 This could explain
the big decrease in VAS in Hazer et al., who only
included patients following microdissection. Rapcan
et al.37 hypothesized that the number of open spinal
surgeries and the extent of epidural fibrosis affect the
success of epiduroscopy negatively and that patients




Figure 2. Visual analogue scale (A) for each study at baseline and
6 and 12 months after epiduroscopy and (B) box andwhisker plot
of combined data at baseline, 6, and 12 months after epiduro-
scopy. M + C, study arm with patients receiving mechanical
adhesiolysis with target drug placement; M, study arm with
patients receiving only mechanical adhesiolysis.
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Takeshima et al.39 performed adhesiolysis based on
fluoroscopic findings of the epidural space and specific
sites around affected nerve roots. Readhesions appeared
to occur faster after epiduroscopy in the central epidural
space than around nerve roots. This correlated with the
finding that patients with dominant nerve root adhe-
sions had an increased long-term benefit from nerve root
adhesiolysis. This suggests that the anatomical location
of adhesions must correlate with the location of pain in
order to have a positive outcome. Rapcan et al.37 also
attributed recurrent pain at 6 months to the formation
of readhesions. There appears to be no correlation
between rigidity of epidural fibrosis and the time interval
between spinal surgery and epiduroscopy.47
Improved selection procedures that aid the identifi-
cation of patients who will benefit from epiduroscopy
are warranted. One promising technique for the iden-
tification of these patients is quantitative sensory testing
(QST). Several studies have used QST to create presur-
gical somatosensory profiles, studying their relation to
postsurgical clinical outcome.48,49 QST can differentiate
between cervical radicular pain and nonspecific neck
pain.49 As patients with predominant nerve root adhe-
sions had an increased long-term benefit from nerve root
adhesiolysis, objective measurement of radicular pain
and sensory function may be predictive of postsurgery
clinical pain outcome.50,51
In conclusion, careful selection of patients for
epiduroscopy will affect the success rate of the proce-
dure. Therefore, future studies need to include the
assessment of prognostic factors for the epiduroscopy
success rate and pain phenotyping using, for instance,
QST measures.
The studies in our review did not report serious
adverse events following epiduroscopy. There are,
however, several case reports describing serious adverse
events. Retinal hemorrhage with acute vision loss has
been reported in two cases.52,53 Another case report
described encephalopathy and rhabdomyolysis follow-
ing dural tear, most likely due to intrathecal neurotox-
icity of contrast agents.54 Other adverse events include
epidural hematoma,55 formation of intradural lum-
bosacral cyst,56 and transient neurological deficits with
seizures during the procedure.57 Considering the poten-
tial risk for patients, it is advised that the epiduroscopy
procedure should be performed in specialized centers.
So far, only “reasonable”10 and “limited”27 evidence
has been described that supports the use of epiduroscopy
Figure 3. Forest plot of visual analogue scale mean difference (A) between baseline and 6 months after epiduroscopy, (B) between
baseline and 12 months after epiduroscopy, both using the generic inverse variance and random effects analysis model. CI, confidence
interval; IV, inverse variance; M, study arm with patients receiving only mechanical adhesiolysis; M + C, study arm with patients
receiving mechanical adhesiolysis with target drug placement; SE, standard error.
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in the treatment of FBSS. Although new studies have
been published, extending the body of evidence, a high-
quality RCT has not been published on the effectiveness
of epiduroscopy compared with conventional therapy,
sham procedures, or other interventions such as neu-
rostimulation.
This systematic review has several limitations. Few
studies are available that objectively compare epiduro-
scopy with other interventions. Therefore, this review
investigated single-arm data prior to and post interven-
tion with long-term follow-up. No control group was
available; hence, the effect of time could not be
accounted for. FBSS patients suffer from a number of
heterogeneous symptoms, with varying duration, extent,
and intensity of symptoms, which may impact clinical
outcome. No clear definition of diagnostic criteria were
mentioned in the studies. Most studies did not describe
the specifics of the initial spinal surgery, which may
further influence the outcome of epiduroscopy.17 The
extent and technical success rate of epiduroscopy were
not always mentioned either. This might be of influence,
considering that 40% of epiduroscopy procedures are
not fully performed due to high-density fibrosis.17
Studies did not specify treatment restrictions, such as
increasing pain medication or crossover to surgery,
during follow-up, possibly aiding the observed positive
effect.
Another important observation that may influence
the outcome of this review is the wide range in baseline
VAS, with a maximum of 9 to a minimum of 6.5. This is
either due to the heterogeneity of the patient population
or other factors such as cultural differences in pain
perception and/or presentation. The location which the
VAS refers to is also inconsistent, including both lower-
back and lower-extremity pain.
Finally, one study had a significant impact on the
results even with a random effect model: Ceylan et al.42
reported a significantly smaller SD than other studies
(tenfold difference), without adequate explanation in
the discussion.
CONCLUSION
When correctly indicated, epiduroscopy demonstrates to
be a promising therapy for patients with FBSS. An
average decrease of around three points in VAS and
20% in ODI is an impressive outcome considering the
often refractory symptoms in patients with FBSS.
Serious adverse events following epiduroscopy have
been described in case reports but were not reported in
the included studies. Taking into account that the
overall quality of evidence is categorized as “moder-
ate” and the corresponding level of recommendation as
“weak,” practitioners should weigh the risks and
benefits of epiduroscopy for their individual patients
with FBSS. Careful assessment of patients who more
likely benefit from the procedure by pain phenotyping
may aid this process. Also the option of neuromodula-




Figure 4. Oswestry Disability Index (A) for each individual study
at baseline and 6 and 12 months after epiduroscopy and (B)
combined in box and whisker plot of combined data at baseline
and 6 and 12 months after epiduroscopy. M, study arm with
patients receiving only mechanical adhesiolysis; M + C, study arm
with patients receiving mechanical adhesiolysis with target drug
placement.
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Figure 5. Forest plot of Oswestry Disability Index mean difference (A) between baseline and 6 months after epiduroscopy and (B)
between baseline and 12 months after epiduroscopy, both using the generic inverse variance and random effects analysis model. CI,
confidence interval; IV, inverse variance; M, study arm with patients receiving only mechanical adhesiolysis; M + C, study arm with
patients receiving mechanical adhesiolysis with target drug placement; SE, standard error.
Figure 6. Scatterplot of percentage (%) of patients experiencing
relief of pain according to respective definitions of individual
studies at 6- and 12-month follow-up after epiduroscopy,
including average (mean) with trendline.
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